MLAB 1315- Hematology Keri Brophy-Martinez Unit 23: CHRONIC MYELOPROLIFERATIVE DISORDERS (MPD)

Slides:



Advertisements
Similar presentations
MYELOPROLIFERATIVE DISEASES By DR. FATIMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Advertisements

MLAB Hematology Keri Brophy-Martinez
Hematology The Study of Blood Blood contains cells, proteins, and sugars Red blood cells transport oxygen- erythrocytes White blood cells are part of the.
NEOPLASTIC DISORDERS OF THE BONE MARROW
Hemostatic System - general information Normal hemostatic system –vessel wall –circulating blood platelets –blood coagulation and fibrynolysis Platelets.
Polycythemia Group C: Melanie, Michele, Sarah.
Myeloproliferative Disorders (Neoplasm)II Dr. Ibrahim. A. Adam.
Myeloproliferarive Disorder
Polycythemia Vera (lots of red cells - for real)
This lecture was conducted during the Nephrology Unit Grand Ground by Nephrology Registrar under Nephrology Division, Department of Medicine in King Saud.
WHO CLASSIFICATION OF MYELOID NEOPLASMS 2000  Chronic myeloproliferative disorders (CMPD)  Myelodysplastic / myeloproliferative diseases (MDS/MPD) 
Acute Myeloid Leukemias (AML)
Unit #5B – Clinical Laboratory Testing Basic Hematology Cecile Sanders, M.Ed., MLS(ASCP)
Myeloproliferative disorders Chris hatton. Proliferate or accumulative Bone marrow produces cells – mainly erythrocytes Bone marrow produces 10.
Chapter 7 Disorders of Blood Cells Lecture 7 The Nature of Disease Pathology for the Health Professions Thomas H. McConnell.
Myeloprolifrative disorders -Chronic Myelogenouse Leukemia - Primary Poly Cythemia ( vira ) - Essential Thrombocythemia - Myelofibrose Myeloid Methaplasia.
MLAB Hematology Keri Brophy-Martinez
The Blood I Functions Components Formation of blood cells D.Rezazadeh Department of Medical Laboratory Science Kermanshah,Faculty of Paramedical.
Polycythemia Emmanuel Akuna Lab values. Normal platelet 150, ,000 CELLS/MM 3 Hemoglobin- men g/dl women g/dl Hematocrit.
Case Study MICR Hematology Spring, 2011 Case # 6 Monique Quiroz Mike Pehl Andrew Ho.
Lecture 2 Red Blood Cells, Anemias & Polycythemias
Myeloid Blastic Transformation of Myeloproliferative Neoplasms A Review of 112 Cases Presenter: Syed Jawad Noor, PGY3 Mentor: Meir Wetzler June 09, 2010.
Myeloproliferative disorders Dr. Tariq Roshan PPSP Department of Hematology.
Myeloproliferative Disorders (MPD) concepts Neoplastic (clonal) disorders of hemopoietic stem cells Over-production of all cell lines, with usually one.
The Chronic Myeloproliferative Disorders (MPD) A JENABIAN MD.
Myeloproliferative disorders Clonal haematopoeitic disorders Proliferation of one of myeloid lineages –Granulocytic –Erythroid –Megakaryocytic Relatively.
BLOOD Disorders.
Myeloproliferative Disorders (MPDs)
MLAB HEMATOLOGY KERI BROPHY-MARTINEZ Myelodysplastic Syndromes.
Myelofibrosis Chronic idiopathic myelofibrosis Progressive fibrosis of the marrow & increase connective tissue element Agnogenic myeloid metaplasia  Extramedullary.
Hypercoagulable States: Polycythemia Vera Chris Caulfield AM Report Oct 20, 2009.
Chicago Medical School
MLAB Hematology Keri Brophy-Martinez
MLAB Hematology Keri Brophy-Martinez
Myeloproliferative Lymphoproliferative & Immunoproliferative disorders.
Blood Disorders and Diseases -Diagnosed by a Blood Count Test - Caused by inheritance, environmental factors, poor diet, old age.
Acute Leukemia Kristine Krafts, M.D..
Definition of polycythemia
Myeloproliferative Diseases Mark D. Browning, M.D. Oncology/Hematology Associates February 24, 2016.
Myeloprolifrative disorders Dr.musa Qasim Hussein Assistant professor Consultant physician 29th feb.2016.
Gary Schiller, MD Nothing to disclose Discussion of off-label drug use: not applicable 56 th ASH Annual Meeting Disclosure Statement.
Myelofibrosis with myeloid metaplasia : Disease overview and non-transplant treatment options Best Practice & Research Clinical Haematology Vol. 19, No.
골수증식 질환 Myeloproliferative disorders (MPD) [ 새로운 분류와 진단 기준 ] 경희의대 종양혈액내과 조 경 삼.
CHAPTER 7 DISORDERS OF BLOOD CELLS & VESSELS. HEMATOPOIESIS Generation of blood cells Lymphoid progenitor cells = lymphocytes (WBCs) Myeloid progenitor.
MLAB Hematology Keri Brophy-Martinez
Thrombocythemia Mark D. Browning, M.D. February 24, 2016.
Nada Mohamed Ahmed, MD, MT (ASCP)i. Objectives chronic myeloid leukaemia (CML) Haematopoietic malignancies Polycythemia vera (PV) Idiopathic myelofibrosis.
Done by: Charlie Amjad Qusar Mohammad Monther Salahat Basil Faiq Haddaden Baraa Ayman Fahmawi.
Myeloprolifrative disorders
Definition of polycythemia
MLAB 1415-Hematology Keri Brophy-Martinez
Acute Leukemia Kristine Krafts, M.D..
Hematocrit.
Myelodysplastic Syndromes Myeloproliferative Disorders
MYELOPROLIFERATIVE DISEASES
MLAB 1415-Hematology Keri Brophy-Martinez
Definition of polycythemia
MYELOPROLIFERATIVE DISORDERS
RBC disorders 5 Ahmad Mansour, MD.
MLAB Hematology Keri Brophy-Martinez
Do you have any suggestions? Please contact us!
Myeloid Neoplasm and Hematopoietic Stem Cell Disorders
Chronic Myeloproliferative Neoplasms (MPN) Ph-negative
Red Blood Cell Disorders
Polycythemia Wendy Blount, DVM.
Chronic Leukemia Kristine Krafts, M.D..
Male patient of 52 years old with a two-year history of fatigue and pruritus of his legs , headache . And visual disturbances . He smoked one pack of.
Polycytemia Dr. Mamlook Elmagraby.
Chronic Leukemia Dr. Noha Noufal.
The Non – Leukemic Myeloproliferative Disorders
Presentation transcript:

MLAB Hematology Keri Brophy-Martinez Unit 23: CHRONIC MYELOPROLIFERATIVE DISORDERS (MPD)

CHRONIC MYELOPROLIFERATIVE DISORDERS (MPD) MPD’s are characterized by a hypercellular bone marrow with increased quantities of one or more cellular lineages in the peripheral blood.

Idiopathic myelofibrosis Characteristics Marrow fibrosis 90% of attempts result in dry tap. Fibroblasts and increased collagen production lock in the marrow contents. Extramedullary hematopoiesis or myeloid metaplasia of spleen and liver NRBC’s and immature WBC’s in the peripheral blood, teardrop red cells, abnormal platelets

Idiopathic myelofibrosis Treatment Transfusion for anemia Iron, folate and B12 Steroids Splenectomy BM transplant

Idiopathic myelofibrosis Prognosis Median survival time is about 5 years from time of diagnosis.

Polycythemias Polycythemia vera Stem cell disorder characterized by a remarkable increase in red blood cell mass and total blood volume. There is also an increase in myeloid and megakaryocytic elements in the bone marrow.

Polycythemia vera Clinical features Patients have a ruddy cyanotic complexion due to congestion of blood vessels. Itching Fever and night sweats Splenomegaly Brain circulatory disorders and TIA’s Onset is usually around 60 years of age.

Polycythemia vera Laboratory features Increased red cell mass with Cr 51 Increased H&H, WBC, plts

Polycythemia vera Treatment Therapeutic phlebotomy for rapid reduction of RBC mass. Radioactive phosphorous for myelosuppression. Prognosis Survival time from diagnosis is 8-15 years 10-15% of patients convert to acute nonlymphocytic leukemia.

Secondary polycythemias There are many causes that all result in increased secretion of erythropoietin Physiologically appropriate increase in erythropoietin High altitude Chronic pulmonary disease Obesity/sleep apnea Defective oxygen transport Smoking High oxygen affinity hemoglobinopathies Physiologically inappropriate increase in erythropoietin Renal disease Neoplasms Endocrine disorders

Relative polycythemia Stress polycythemia Dehydration causes decrease plasma volume

Essential thrombocythemia Rare chronic MPD in which platelets are increased and function is abnormal. Platelet count is > 600,000 x 10 9 /L